GlaxoSmithKline PLC — Director's Dealing 2016

Feb 25, 2016

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 1620Q

GlaxoSmithKline PLC

25 February 2016

GlaxoSmithKline plc

Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons

In accordance with DTR 3.1.4 R(1)(a) and (c) GlaxoSmithKline plc (GSK) was advised on 25 February 2016 of the following increases in the notional allocation of GSK American Depositary Shares (ADSs) on 23 February 2016, at a price of $38.64 per ADS, following the revaluation of the cash element of the notional investment held within the GSK 401(K) plan:

Director/PDMR	Number of ADSs
Dr M M Slaoui	51

Connected Person	Number of ADSs
Dr K Slaoui (Connected Person of Dr M M Slaoui)	4

V A Whyte

Company Secretary

25 February 2016

This information is provided by RNS

The company news service from the London Stock Exchange

END

RDSFELFLQLFLBBL